1 April 2026 - The April 2026 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few major new listings of note this month:

• Ivacaftor (Kalydeco) - new indication
• Elexacaftor with tezacaftor and ivacaftor and ivacaftor (Trikafta) - new indication
• Vanzacaftor with tezacaftor and deutivacaftor (Alyftrek) - new combination product
• Brentuximab vedotin (Adcetris) - new indication

Read New Zealand Pharmaceutical Schedule update